Second opinion on radical robotic prostatectomy in boston hospitals
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Ah, got it! You're looking for second opinion resources at Boston hospitals for radical robotic prostatectomy. That's a smart approach to your prostate cancer care.
Let me help you with both understanding your options AND finding quality second opinion providers in the Boston area.
Getting a Second Opinion on Robotic Prostatectomy
According to NCCN Guidelines for Prostate Cancer, a second opinion is particularly important because:
- Treatment choice depends heavily on your specific risk category (low, intermediate, high-risk)
- Robotic prostatectomy is one option among several (radiation, active surveillance, hormone therapy)
- Different surgeons may have different expertise and outcomes
- Your individual health factors matter significantly
Top Boston-Area Hospitals for Prostate Cancer Second Opinions
Major Academic Centers with Urology Oncology Programs:
-
Massachusetts General Hospital (Boston)
- Part of Mass General Brigham system
- Strong urology oncology department
- Contact: Urology Department for second opinion consultation
-
Brigham and Women's Hospital (Boston)
- Comprehensive cancer center
- Experienced robotic surgery program
- Contact: Dana-Farber Cancer Institute (affiliated)
-
Dana-Farber Cancer Institute (Boston)
- Leading cancer center
- Multidisciplinary prostate cancer team
- Offers second opinion consultations
-
Boston Medical Center
- Academic medical center with urology oncology
- Second opinion services available
-
Lahey Hospital & Medical Center (Burlington, MA - near Boston)
- Strong urology program
- Robotic surgery expertise
How to Request a Second Opinion
Steps:
-
Gather your records:
- Pathology report (Gleason score, stage)
- PSA level and trend
- Imaging (MRI, CT if done)
- Any genetic testing results (BRCA, Lynch syndrome, etc.)
-
Contact the hospital's second opinion program - Most major centers have dedicated second opinion services
-
Schedule with a urologic oncologist - Not just a general urologist; you want someone specializing in cancer
-
Prepare questions (see below)
Key Questions to Ask During Your Second Opinion
Before your appointment, prepare to discuss:
-
"Based on my Gleason score, PSA, and stage, what is my risk category, and how does that influence treatment options?"
-
"Why do you recommend robotic prostatectomy specifically for my situation? What are the alternatives?"
-
"What are your outcomes with robotic prostatectomy? (Complication rates, continence, erectile function)"
-
"What is your experience with my specific risk category?"
-
"If I choose surgery, what is your approach to nerve preservation?" (Important for erectile function)
-
"What would you recommend if I were your family member?"
Understanding Your Decision
According to the American Cancer Society, the choice between robotic prostatectomy and other treatments depends on:
- Your age and overall health
- Your risk category
- Your preferences regarding side effects (incontinence, erectile dysfunction)
- Your life expectancy
Active surveillance (watchful waiting) is often appropriate for low-risk disease. Radiation may be better for some intermediate/high-risk cases. Robotic surgery is excellent for appropriate candidates.
What to Bring to Your Second Opinion
✅ All pathology reports ✅ PSA results (current and historical) ✅ Imaging reports (MRI, ultrasound, CT) ✅ List of current medications ✅ Questions written down ✅ Your original oncologist's recommendation letter (if available)
Next Steps: To give you more specific guidance, it would help to know:
- Your Gleason score and PSA level
- Your stage (if known)
- Whether you've had imaging (MRI, bone scan)
- Your age and overall health status
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2